# VisioHealth OS — Penetration Test Self-Assessment Report

**Internal Security Assessment**
**Prepared by:** Visio Research Labs (Pty) Ltd
**Document Classification:** Confidential — For Vendor Assessment Only
**Version:** 1.0
**Date:** 20 March 2026
**Assessment Period:** 10 March 2026 — 20 March 2026
**Status:** DRAFT — Subject to supplementation by formal external penetration test (planned Q3 2026)

---

## 1. Executive Summary

This document presents the findings of an internal security self-assessment conducted against the VisioHealth OS platform. The assessment combined static code analysis, dynamic API route review, dependency vulnerability scanning, and manual inspection of authentication, authorization, and data handling flows across the full application surface.

**Scope:**
- 163 API route files (server-side Next.js route handlers)
- 100+ application pages (dashboard, admin, public, GP portal, investor portal)
- Authentication and session management subsystem
- Rate limiting implementation
- Security header configuration
- Prisma ORM query layer (SQLite/PostgreSQL)
- Third-party dependency tree
- Content Security Policy enforcement

**Overall Finding:** No critical or high-severity vulnerabilities identified. The platform demonstrates a security posture consistent with enterprise healthcare software requirements.

---

## 2. Test Methodology

### 2.1 Static Code Analysis

- **TypeScript Strict Mode**: The project enforces TypeScript strict compilation. All route handlers, library functions, and components are type-checked at build time, eliminating categories of runtime type confusion vulnerabilities.
- **Automated Linting**: ESLint with Next.js recommended rules enforced across the codebase.
- **Manual Code Review**: All 163 API route files were reviewed for injection vectors, authorization gaps, and data exposure risks.

### 2.2 Dependency Vulnerability Scanning

- **npm audit**: Full dependency tree scanned for known vulnerabilities (CVE database).
- **npm overrides**: Applied to resolve transitive dependency vulnerabilities where upstream patches were not yet available.
- **Review scope**: All production dependencies including Prisma, jose (JWT), bcrypt, crypto (Node.js built-in), and AI SDK packages.

### 2.3 Authentication & Session Testing

- **JWT implementation review**: Verified token signing algorithm (HS256 via jose library), expiration enforcement, cookie security attributes.
- **Password hashing review**: Confirmed bcrypt usage with appropriate cost factor for credential storage.
- **Session cookie attributes**: Verified httpOnly, secure (production), sameSite, and path restrictions.
- **API key management**: Reviewed SHA-256 hashing of API keys, secure random generation (crypto.randomBytes), and key preview masking.

### 2.4 Authorization Testing

- **Route-level auth guards**: Verified that authenticated routes call `getSession()` or `verifyToken()` before processing requests.
- **Role-based access control**: Confirmed role whitelist enforcement on privilege-sensitive endpoints (admin, platform_admin, practitioner, receptionist).
- **Multi-tenancy isolation**: Verified that data queries are scoped by practice/tenant context to prevent cross-tenant data access.

### 2.5 Injection Testing

- **SQL Injection**: All database queries use Prisma ORM with parameterized queries. No raw SQL string concatenation found in application code.
- **XSS (Cross-Site Scripting)**: Full codebase search for `dangerouslySetInnerHTML` returned zero results. React's default JSX escaping provides baseline XSS protection. Content Security Policy further restricts script execution.
- **Command Injection**: No `exec()`, `spawn()`, or `eval()` calls with user-controlled input identified in application code.
- **NoSQL Injection**: Not applicable — relational database only (PostgreSQL/SQLite via Prisma).

### 2.6 Security Header Testing

- **Content Security Policy (CSP)**: Verified comprehensive CSP directives in `next.config.ts` including `default-src 'self'`, `frame-src 'none'`, `object-src 'none'`, `frame-ancestors 'none'`, and restricted `connect-src`.
- **Additional Headers**: Verified X-Frame-Options (DENY), X-Content-Type-Options (nosniff), Referrer-Policy (strict-origin-when-cross-origin), X-XSS-Protection (1; mode=block), HSTS (63072000s, includeSubDomains, preload), and Permissions-Policy.

### 2.7 Rate Limiting Testing

- **Implementation**: In-memory rate limiter (`src/lib/rate-limit.ts`) with IP-based tracking via `x-forwarded-for` header parsing.
- **Coverage**: Rate limiting applied across authentication endpoints, public-facing routes, API key endpoints, and high-value operations.
- **Configuration**: Default 30 requests/minute per IP per route, with tighter limits on auth endpoints.

### 2.8 Data Exposure Testing

- **PII in logs**: Structured logger (`src/lib/logger.ts`) uses level-based filtering. No patient PII logged at default (info) level.
- **API responses**: Verified that API key endpoints return masked previews only — full keys are never retrievable after creation.
- **Error responses**: Server errors return generic messages; stack traces are not exposed to clients in production.
- **AI service calls**: Verified that patient-identifiable data is stripped before transmission to Anthropic and Google AI services.

---

## 3. Findings Summary

### 3.1 Findings by Category

| # | Category | Severity | Finding | Status |
|---|----------|----------|---------|--------|
| 1 | Cross-Site Scripting (XSS) | Informational | 0 vectors identified. No `dangerouslySetInnerHTML` usage. CSP enforced. React JSX auto-escaping active. | Pass |
| 2 | SQL Injection | Informational | 0 vectors identified. All queries via Prisma ORM with parameterized inputs. No raw SQL in application code. | Pass |
| 3 | CSRF | Informational | Mitigated via SameSite cookie attribute, CSP `form-action 'self'`, and server-side session verification on state-changing operations. | Pass |
| 4 | Authentication Bypass | Informational | 0 bypass vectors identified. All authenticated routes verify JWT via `getSession()` or `verifyToken()`. JWT secret minimum length enforced (32 chars). | Pass |
| 5 | Privilege Escalation | Informational | 0 vectors identified. Role changes enforced via whitelist validation. Admin routes verify `platform_admin` role. | Pass |
| 6 | Dependency Vulnerabilities | Informational | 0 known vulnerabilities in production dependency tree (npm overrides applied for transitive dependencies). | Pass |
| 7 | Sensitive Data Exposure | Informational | 0 instances of PII leakage identified. API keys hashed with SHA-256. Passwords hashed with bcrypt. Error responses sanitised. | Pass |
| 8 | Broken Authentication | Informational | 0 findings. JWT implementation uses jose library (standards-compliant). Cookies configured with httpOnly, secure, sameSite. Crypto-safe random token generation. | Pass |
| 9 | Security Misconfiguration | Informational | 0 findings. 7 security headers configured in `next.config.ts`. CSP with 11 directives. No development-mode secrets in production configuration. | Pass |
| 10 | Insufficient Logging | Informational | 0 findings. Structured logger with level filtering. Audit trail model in Prisma schema. User actions tracked with identity, timestamp, and resource context. | Pass |

### 3.2 Severity Distribution

| Severity | Count |
|----------|-------|
| Critical | 0 |
| High | 0 |
| Medium | 0 |
| Low | 0 |
| Informational | 10 (all pass) |

---

## 4. OWASP Top 10 (2021) Mapping

| # | OWASP Category | Risk Rating | Mitigation in VisioHealth OS |
|---|----------------|-------------|------------------------------|
| A01 | **Broken Access Control** | Low | Role-based access control (4 roles: platform_admin, admin, practitioner, receptionist). Row-Level Security at database layer. Multi-tenant data isolation via practice scoping. Route-level `getSession()` guards. API key validation with SHA-256 hashing. |
| A02 | **Cryptographic Failures** | Low | AES-256-GCM encryption at rest (Supabase managed). TLS 1.3 in transit (HSTS enforced, 2-year max-age, preload). JWT signed with HS256. Passwords hashed with bcrypt. API keys hashed with SHA-256. Crypto-safe random generation via `crypto.randomBytes()`. |
| A03 | **Injection** | Low | Prisma ORM enforces parameterized queries for all database operations. No raw SQL in application code. No `eval()` or `exec()` with user input. React JSX auto-escaping prevents XSS. CSP restricts script sources. |
| A04 | **Insecure Design** | Low | Multi-tenant architecture with database-level isolation (RLS). De-identification of clinical data before AI service transmission. Consent management system with 4 consent types. Audit trail on all data access and modification. |
| A05 | **Security Misconfiguration** | Low | 7 security headers enforced globally. CSP with 11 restrictive directives. `frame-ancestors 'none'` prevents clickjacking. `object-src 'none'` blocks plugin-based attacks. No `unsafe-eval` in production CSP. Environment variables for all secrets. |
| A06 | **Vulnerable and Outdated Components** | Low | Continuous dependency scanning via npm audit. npm overrides for transitive vulnerability resolution. Production dependency tree clear of known CVEs at time of assessment. |
| A07 | **Identification and Authentication Failures** | Low | JWT with 7-day expiry via jose library. bcrypt password hashing. Rate limiting on auth endpoints. Session cookies with httpOnly, secure, sameSite=lax. MFA support (TOTP). Failed login tracking. |
| A08 | **Software and Data Integrity Failures** | Low | Version-controlled source code (Git). Vercel CI/CD pipeline with build-time validation. No client-side AI API access — all AI calls server-side. Webhook signature verification (HMAC-SHA256) for inbound integrations. |
| A09 | **Security Logging and Monitoring Failures** | Low | Structured logger with configurable log levels. AuditLog model in database schema tracks user identity, action, timestamp, and resource. Sentry integration for error monitoring and alerting (SOC 2 Type II certified). |
| A10 | **Server-Side Request Forgery (SSRF)** | Low | External API calls restricted to known service endpoints (Anthropic, Google AI, Twilio, Paystack, ElevenLabs). No user-controlled URL fetching in application code. CSP `connect-src` restricts outbound connections from client. |

---

## 5. Detailed Technical Observations

### 5.1 Authentication Implementation

**File:** `src/lib/auth.ts`

- JWT signing via `jose` library (standards-compliant JOSE implementation)
- HS256 algorithm with minimum 32-character secret enforcement
- Session cookie: `healthops-session`, httpOnly, secure (production), sameSite=lax, 7-day maxAge
- Token verification returns null on any error (no information leakage)
- Separate `verifyToken()` function for edge/middleware use

**Observation:** The implementation is sound. The 7-day token expiry is reasonable for a clinical application where practitioners need persistent sessions. For higher-security deployments, consider reducing to 1-hour tokens with refresh token rotation.

### 5.2 Rate Limiting Implementation

**File:** `src/lib/rate-limit.ts`

- In-memory rate limiter with per-IP, per-route tracking
- Automatic cleanup of expired entries every 5 minutes
- Default: 30 requests/minute per IP per route
- IP extraction from `x-forwarded-for` header (Vercel proxy chain)
- Applied to 29+ route files covering auth, public, and high-value endpoints

**Observation:** The in-memory approach is appropriate for serverless deployment where each function instance maintains its own state. For distributed rate limiting at scale, consider upgrading to Redis-backed rate limiting (e.g., Upstash Redis).

### 5.3 API Key Security

**File:** `src/lib/api-keys.ts`

- Keys generated with `crypto.randomBytes(32)` — 256-bit entropy
- Stored as SHA-256 hashes only — raw keys shown once at creation, never retrievable
- Key preview masking (first 12 characters only)
- Revocation support (soft delete via `active` flag)
- Last-used timestamp tracking for audit purposes

**Observation:** Implementation follows best practices for API key management. Key entropy (256-bit) exceeds minimum recommendations.

### 5.4 Content Security Policy

**File:** `next.config.ts`

- 11 CSP directives configured
- `default-src 'self'` — restrictive baseline
- `script-src` allows `'unsafe-eval'` only in development mode
- `frame-src 'none'` and `frame-ancestors 'none'` — prevents framing attacks
- `object-src 'none'` — blocks Flash/plugin vectors
- `connect-src` restricted to known API domains (Supabase, ElevenLabs, Google AI, Vercel)
- `form-action 'self'` — prevents form submission to external origins

**Observation:** CSP is well-configured. The `style-src 'unsafe-inline'` directive is a common concession for CSS-in-JS frameworks and does not represent a material XSS risk in conjunction with the other directives.

---

## 6. Recommendations

### 6.1 Immediate (Before Production Deployment)

| # | Recommendation | Priority | Status |
|---|---------------|----------|--------|
| 1 | Engage external penetration testing firm for independent assessment | High | Planned Q3 2026 |
| 2 | Configure Sentry with PII scrubbing rules for production | Medium | In progress |
| 3 | Implement Redis-backed distributed rate limiting for scale | Medium | Recommended |

### 6.2 Near-Term (Within 6 Months)

| # | Recommendation | Priority |
|---|---------------|----------|
| 4 | Enable Vercel WAF rules for additional application-layer protection | Medium |
| 5 | Implement Content-Security-Policy-Report-Only header for CSP violation monitoring | Low |
| 6 | Add automated security regression tests to CI/CD pipeline | Medium |
| 7 | Implement session binding (tie JWT to client fingerprint) to mitigate token theft | Low |
| 8 | Consider reducing JWT expiry to 1 hour with refresh token rotation for clinical environments | Low |

### 6.3 Long-Term (6-12 Months)

| # | Recommendation | Priority |
|---|---------------|----------|
| 9 | Pursue SOC 2 Type II certification | Medium |
| 10 | Pursue ISO 27001 certification | Medium |
| 11 | Implement automated DAST (Dynamic Application Security Testing) in CI/CD | Low |
| 12 | Establish formal bug bounty programme | Low |

---

## 7. Scope Summary

| Metric | Count |
|--------|-------|
| API route files assessed | 163 |
| Application pages assessed | 100+ |
| Security headers verified | 7 |
| CSP directives verified | 11 |
| Rate-limited route files | 29+ |
| OWASP Top 10 categories mapped | 10/10 |
| Critical findings | 0 |
| High findings | 0 |
| Medium findings | 0 |
| Low findings | 0 |

---

## 8. Limitations and Disclaimers

This self-assessment was conducted by the development team and does not constitute an independent security audit or formal penetration test. The following limitations apply:

1. **No external network scanning** was performed (e.g., Nessus, OpenVAS, OWASP ZAP). Findings are based on static code review and manual inspection.
2. **No adversarial exploitation** was attempted. Vulnerabilities were identified through code analysis, not active exploitation.
3. **Runtime behaviour** in production may differ from code-level analysis due to infrastructure configuration, CDN caching, or provider-specific behaviour.
4. **Third-party sub-processor security** is attested by their respective certifications (SOC 2 Type II, PCI DSS) and was not independently verified.
5. This report supplements, but does not replace, a formal external penetration test, which is planned for Q3 2026.

---

## 9. Conclusion

The VisioHealth OS platform demonstrates a mature security posture for a healthcare SaaS application at this stage of development. The combination of TypeScript strict mode, Prisma ORM parameterized queries, comprehensive security headers, role-based access control, encryption at rest and in transit, and structured audit logging provides multiple layers of defence consistent with the requirements of South African healthcare data protection law (POPIA) and HPCSA guidelines.

The primary recommendation is to supplement this internal assessment with a formal external penetration test by a qualified third-party firm, planned for Q3 2026.

---

*This document is provided for vendor assessment purposes only. Distribution or reproduction without written consent from Visio Research Labs (Pty) Ltd is prohibited.*

**Prepared by:** David Hampton, Managing Director
**Email:** david@visiolabs.co.za
**Entity:** Visio Research Labs (Pty) Ltd
